Alzheimer's sleep loss tied to overactive brain immune cells
A study in mice identifies overactive immune cells in the brain as a driver of sleep loss in Alzheimer's, offering a new treatment target.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
Drugmakers seek to intervene in lawsuit over 340B rebate pilot
AbbVie, BMS, and Boehringer Ingelheim argue HHS cannot adequately defend their interests as hospitals sue to block the second attempt at the 340B rebate program.
Theranos Whistleblower: Holmes Still Lying in New Film
Tyler Shultz, a former Theranos employee and whistleblower, argues that Nathan Fielder's film about Elizabeth Holmes is art, not documentary, and that Holmes continues to mislead by showing a prototype rather than the faulty device used on patients.
Saudi Arabia's biotech ecosystem shifts from strategy to concrete deals
New agreements, infrastructure milestones, and faster trial approvals signal that Saudi Arabia's National Biotechnology Strategy is moving into an execution phase.
Rare Total Colon Duplication Masqueraded as Infant Constipation
A case report describes an infant whose persistent constipation and distention were caused by a complete duplication of the colon and rectum, a rare congenital anomaly.
Health systems shift to procurement governance to control indirect spend
A sponsored industry report outlines five strategies health systems are using to centralize and standardize non-clinical purchasing.
Trump orders new NIH women’s health division and White House task force
An executive order creates a dedicated NIH division and a White House task force to coordinate research on conditions that disproportionately affect women.
China Moves to Restrict Foreign Biotech Acquisitions
A STAT report says China is tightening its stance on foreign takeovers of biotech companies, a policy shift with potential industry-wide implications.
Biomedical Researchers Join Exodus as U.S. Funding Cuts Bite
A wave of scientists, including biomedical researchers, is leaving the U.S. for stable funding abroad, an unprecedented and concerning shift.
No Surprises Act Arbitrators Reap Tech-Like Profits
A STAT investigation finds that the arbitration system meant to settle surprise medical bills has become a lucrative windfall for the arbitrators themselves.
Measles Resurgence Becomes a Political Liability for Republicans
Two former Republican physicians argue that mixed vaccine messaging and a record measles year are turning voters away from GOP candidates.
What healthcare leaders should weigh about AI-native EHRs
A sponsored analysis argues that AI built into EHR platforms, rather than bolted on, can reduce documentation time and improve workflow continuity.
Study finds low extractables in single-use systems for ADC manufacturing
A Cytiva-sponsored extractables study found low levels of leachable compounds in three single-use components exposed to ADC solvents, supporting their use in antibody-drug conjugate production.
AI payer intelligence targets rising claims denial costs
A sponsored industry analysis argues that AI-driven payer intelligence can help providers shift from reactive denial recovery to proactive prevention.
Disc's bitopertin succeeds in Phase 3, setting up FDA resubmission
Positive Phase 3 data give Disc Medicine another chance to win approval for the rare disease drug bitopertin after an FDA rejection earlier this year.
Doctors Urged to Discuss Looming Health Policy Cuts With Patients
A physician argues clinicians have an ethical duty to warn patients how Medicaid and insurance changes will affect their care.
Skin Stem Cells Behave Differently by Sex, Mouse Study Finds
Tracking skin stem cells in living mice reveals that female cells act in synchrony while male cells act independently, a difference tied to sex hormones.
Stable Midlife Work Linked to Healthier Aging Brains
A Columbia University study finds that steady employment in midlife is associated with better cognitive health later, while job instability and early retirement are tied to dementia risk.